Pregled bibliografske jedinice broj: 844116
Volanesorsen
Volanesorsen // Drugs of the future, 41 (2016), 7; 417-421 doi:10.1358/dof.2016.041.07.2485368 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 844116 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Volanesorsen
(Volanesorsen Antisense oligonucleotide targeting ApoC-III Treatment of familial chylomicronemia syndrome Treatment of hypertriglyceridemia Treatment of lipodystrophy)
Autori
Pećin, Ivan ; Nedić, M. ; Reiner, Željko
Izvornik
Drugs of the future (0377-8282) 41
(2016), 7;
417-421
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Volanesorsen ; ISIS-304801 ; Apolipoprotein C-III ; Monoclonal antibody ; Triglycerides ; Cardiovascular risk
Sažetak
Elevated triglycerides have been recognized as an important factor of many pathological states and lowering them has become more and more a relevant factor in taking care of patients who suffer from the disease, obesity, metabolic syndrome and diabetes type 2. Hypertriglyceridemia is also associated with some rare diseases like familial chylomicronemia syndrome and familial partial lipodystrophy that currently have limited therapeutic options.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
108-1080134-0121 - Percepcija i prevencija čimbenika rizika za aterosklerozu u Hrvatskoj (Reiner, Željko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
